The News Review:

- Aastrom Commends Expansion of Federal Support for Stem Cell Research
- Premier Research Expands its Medical Device perations to the …
- RNCS Releases a New Report- Booming Clinical Trials Market in India

Aastrom Commends Expansion of Federal Support for Stem Cell Research
MSNBC
While the Administration’s action this week primarily focuses on funding for embryonic stem cell research this level of interest also benefits research into therapeutic applications of stem cells from other sources” said George W. Dunbar President and CE of Aastrom. “Grant funding from the federal government is a vital source support required to sustain new clinical research. Medical breakthroughs in this sector have the potential of providing enormous benefit to patients. We look forward to reporting advancements in our clinical development efforts in the future. Story continues below ?advertisement |.
Related from Indoorenvirons: Cancer threat removed from stem cells scientists say

Premier Research Expands its Medical Device perations to the …
PR Newswire (press release)
I look forward to growing this group” he commented. About Premier ResearchPremier Research is a leading global solutions-driven CR committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. They are leaders in clinical research for analgesia neuroscience oncology and infectious disease and have a wealth of experience in medical device and pediatric research. Premier Research has 30 offices and operates in more than 30 countries across North America and Europe employing more 1200 clinical professionals dedicated first and foremost to fulfilling each client’s requirements in a timely accurate and cost-effective manner. This includes a strong international network of monitors and project management professionals combined with regulatory data management statistical scientific and medical experts and staff at our well-established network of dedicated clinical sites.

RNCS Releases a New Report- Booming Clinical Trials Market in India
PR.com (press release)
These include parameters such as patient pool regulatory environment cost infrastructure human resources and past performance in conducting clinical trials. Thus this analytical study serves as a useful guide for drug manufacturers CRs consultants and investors who are planning to enter the Indian clinical trials market.